Search clinical trials for: Docetaxel, Doxorubicin or Epirubicin, Cyclophosphamide

Total 1449 results

UNICANCER

Completed

Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

Lung Cancer

France
Translational Oncology Research International
Genentech, Inc.

Completed

Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299)

Breast Cancer

Canada, United States, Ireland
National Cancer Institute (NCI)

Completed

Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer

Breast Cancer | Breast Neoplasm

United States
Ludwig-Maximilians - University of Munich

Completed

Combination Chemotherapy in Treating Women With Breast Cancer

Breast Cancer

Germany
Universitaire Ziekenhuizen KU Leuven

Completed

Caelyx Adjuvant in Elderly Breast Cancer

Breast Cancer | Elderly

Belgium
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer

Breast Cancer | Drug/Agent Toxicity by Tissue/Organ

United States
Merck Sharp & Dohme LLC

Completed

Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)

Breast Neoplasm
UNICANCER

Completed

Combination Chemotherapy in Treating Women With Stage I Breast Cancer

Breast Cancer

France
Lund University Hospital
Danish Breast Cancer Cooperative Group; Swedish Breast Cancer Group; Finnish... and other collaborators

Recruiting

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Breast Cancer | Triple Negative Breast Neoplasms

Denmark, Sweden
Hackensack Meridian Health
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Pfizer; Amgen

Completed

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Breast Cancer | Adenocarcinoma of the Breast

United States
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Breast Cancer | Fatigue | Neurotoxicity | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment | Long-term Effects Secondary to Cancer Therapy in Adults | Chemotherapeutic Agent Toxicity

United States
West German Study Group
Sanofi; Roche Pharma AG

Terminated

Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)

Breast Cancer

Germany
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Cancer

United States
NCIC Clinical Trials Group

Completed

Tamoxifen in Treating Women With High-Risk Breast Cancer

Breast Cancer

Canada
Seagen Inc.

Terminated

Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

Breast Cancer

United States
SCRI Development Innovations, LLC
Aventis Pharmaceuticals; Ortho Biotech, Inc.

Completed

Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer

Breast Cancer

United States
ARCAGY/ GINECO GROUP

Completed

Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer

Metastatic Breast Cancer

France
UNICANCER

Terminated

Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer

Breast Cancer

France
National Taiwan University Hospital

Completed

Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm (TaiNAC)

Breast Cancer | Chemotherapy

Taiwan
Seagen Inc.

Completed

Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

Prostatic Neoplasms

United States
Samyang Biopharmaceuticals Corporation

Recruiting

Compare the Efficacy and the Safety of Doxorubicin and Cyclophosphamide Followed by Taxotere Versus Doxorubicin and Cyclophosphamide Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer

Korea, Republic of
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Shanghai Jiao Tong University School of Medicine

Recruiting

Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer (TCTN)

Breast Neoplasm

China
Medical Research Council

Completed

Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer

Breast Cancer

United Kingdom, South Africa
Medical Research Council

Unknown

Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer

Ovarian Cancer

United Kingdom
Azienda Ospedaliero-Universitaria Careggi

Completed

Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer (ANCHISES)

Metastatic Prostate Cancer | Elderly Patients

Italy
Sun Yat-sen University

Unknown

Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Mansoura University

Completed

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer (NMIBCIVT)

Carcinoma of Urinary Bladder, Superficial

Egypt
Shanghai Jiao Tong University School of Medicine

Terminated

NeoMET Study in Neoadjuvant Treatment of Breast Cancer (NeoMET)

Safety | pCR Rate | BCT Rate

China
Fudan University

Recruiting

Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer (CLOVER)

Breast Cancer

China
Hoffmann-La Roche

Completed

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer (BERENICE)

Breast Cancer

United States, Canada, Denmark, France, Italy, Poland, Portugal, Spain, United Kingdom, Norway, Germany, Mexico
West German Study Group
Sanofi; Amgen

Completed

Anthracycline-free Taxane Based Chemotherapy in Patients With HER2/Neu Negative Early Breast Cancer (planB)

Primary Breast Cancer | Her2 Non-overexpressing

Germany
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer

Breast Cancer

United States
Imunon

Unknown

Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer

Breast Cancer

United States
University of Wisconsin, Madison
Amgen

Completed

Dose Dense TC + Pegfilgrastim Support for Breast Cancer (ddTC)

Female Breast Cancer

United States
ETOP IBCSG Partners Foundation

Completed

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer (15-95)

Breast Cancer

Switzerland, Australia
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Aventis Pharmaceuticals

Completed

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Breast Cancer

United States
Sun Yat-sen University

Unknown

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Unrecognized Condition
University of Yamanashi

Unknown

Study of Chemo-Immunotherapy in Head and Neck Cancer Patients

Head and Neck Cancer

Japan
IRCCS San Raffaele

Completed

Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer (PACT-9)

Pancreatic Cancer

Italy
Radboud University Medical Center
Sanofi; Amgen

Completed

Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer. (INTENS)

Breast Cancer

Netherlands
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.

Advanced Endometrial Cancer | Sarcoma of Uterus

China
Zivena

Unknown

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

NSCLC

United States
UNICANCER

Completed

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

France
M.D. Anderson Cancer Center
Eisai Inc.

Completed

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Breast Cancer

United States
UNICANCER

Completed

Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer (PEGASE07)

Inflammatory Breast Cancer
University of Michigan Rogel Cancer Center

Completed

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

Prostate Cancer

United States
Xijing Hospital

Unknown

Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer

Breast Cancer

China
Peregrine Pharmaceuticals

Completed

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

Non-small-cell Lung Cancer

United States, India, Georgia, Russian Federation, Ukraine

3

Subscribe